Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding

Helicobacter

Volumn 12, Issue 4, 2007, Pages 279-286

  Gisbert, Javier P ^a,k   Calvet, Xavier ^b   Feu, Faust ^c   Bory, Felipe ^d   Cosme, Angel ^e   Almela, Pedro ^f   Santolaria, Santos ^g   Aznárez, Rosario ^h   Castro, Manuel ⁱ   Fernández, Nuria ^j   García Grávalos, Rafael ^a   Cañete, Nuria ^d   Benages, Adolfo ^f   Montoro, Miguel ^g   Borda, Fernando ^h   Pérez Aisa, Angeles ^j   Piqué, Jose María ^c  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b HOSPITAL DE SABADELL   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e HOSPITAL DONOSTIA   (Spain)

^f HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^g HOSPITAL SAN JORGE   (Spain)

^h Universidad Pública de Navarra   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^j HOSPITAL COSTA DEL SOL   (Spain)

^k NONE   (Spain)

more..

Author keywords

Helicobacter pylori; Peptic ulcer bleeding; Proton pump inhibitor; Upper gastrointestinal bleeding; Upper gastrointestinal hemorrhage

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; RANITIDINE; RANITIDINE BISMUTH CITRATE; RIFABUTIN; TETRACYCLINE;

ADULT; ARTICLE; BREATH ANALYSIS; CONTROLLED STUDY; DRUG TREATMENT FAILURE; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INCIDENCE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PYLORUS; RECURRENT DISEASE; STOMACH ULCER; TREATMENT DURATION; TREATMENT OUTCOME; UREA BREATH TEST;

HELICOBACTER PYLORI;

EID: 34547556723     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00490.x     Document Type: Article

References (60)

1. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994 331 : 717 27.
2. Mignon M, Penston JG, Deltenre M, Ruszniewski P, Dobrill G. Natural history of duodenal ulcer disease: are we at a turning point? Gastroenterol Int 1994 7 : 95 113.
3. Petersen H, Kristensen P, Johannessen T, Kleveland PM, Dybdahl JH, Myrvold H. The natural course of peptic ulcer disease and its predictors. Scand J Gastroenterol 1995 30 : 17 24.
4. Laine LA. Helicobacter pylori and complicated ulcer disease. Am J Med 1996 100 : 52S 57S discussion 57S 59S.
5. Murray WR, Cooper G, Laferla G, Rogers P, Archibald M. Maintenance ranitidine treatment after haemorrhage from a duodenal ulcer. A 3-year study. Scand J Gastroenterol 1988 23 : 183 7.
6. Jensen DM, Cheng S, Kovacs TO, et al. A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer. N Engl J Med 1994 330 : 382 6.
7. Kuipers EJ, Thijs JC, Festen HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995 9 : 59 69.
8. Gisbert JP, Pajares JM. Helicobacter pylori and bleeding peptic ulcer: what is the prevalence of the infection in patients with this complication? Scand J Gastroenterol 2003 38 : 2 9.
9. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996 110 : 1244 52.
10. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994 272 : 65 9.
11. Soll AH. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA 1996 275 : 622 9.
12. Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez-Munoz JE. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev 2004 : CD004062.
13. Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez-Munoz E. Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther 2004 19 : 617 29.
14. Gisbert JP. Prevention of bleeding peptic ulcer recurrence by Helicobacter pylori eradication. Gastroenterol Hepatol 2005 Nov 28(9) : 567 75.
15. Gisbert JP, Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol 2006 101 : 848 63.
16. Gisbert JP, Badia X, Roset M, Pajares JM. The TETRA study: a prospective evaluation of Helicobacter pylori 'test-and-treat' strategy on 736 patients in clinical practice. Helicobacter 2004 9 : 28 38.
17. Amendola M, Farias R, Katz J, et al. [Absence of bleeding recurrence of peptic ulcer after long term follow-up of successful eradication of Helicobacter pylori]. Acta Gastroenterol Latinoam 1999 29 : 47 50.
18. Arkkila PE, Seppala K, Kosunen TU, et al. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer. Am J Gastroenterol 2003 98 : 2149 56.
19. Bataga S, Bratu B, Bancu L, Haydu C, Torok I, Dudea C. The treatment in bleeding duodenal ulcer. Gut 1997 41 (Suppl.3 A167.
20. Capurso G, Annibale B, Osborn J, et al. Occurrence and relapse of bleeding from duodenal ulcer: respective roles of acid secretion and Helicobacter pylori infection. Aliment Pharmacol Ther 2001 15 : 821 9.
21. Di Mario F, Salandin S, Kusstatscher S, et al. Eradication of Helicobacter pylori (Hp) infection in preventing peptic ulcer bleeding. Gut 1997 41 (Suppl.3 A203.
22. Fakhreih S, Rahemi M, Dehbashi N, et al. Eradication of Helicobacer pylori vs ranitidine maintenance therapy for prevention of duodenal ulcer rebleeding. Gut 1995 37 (Suppl.2 A236.
23. Gisbert JP, Boixeda D, Aller R, et al. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence]. Med Clin (Barc) 1999 112 : 161 5.
24. Graham DY, Hepps KS, Ramirez FC, Lew GM, Saeed ZA. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993 28 : 939 42.
25. Huelin Benitez J, Jimenez Perez M, Duran Campos A, et al. Haemorrhagic relapse in duodenal ulcers after eradication of Helicobacter pylori. Gut 1998 43 (Suppl.2 A101.
26. Jaspersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammar CH. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995 41 : 5 7.
27. Jaspersen D, Korner T, Schorr W, Brennenstuhl M, Hammar CH. Omeprazole-amoxycillin therapy for eradication of Helicobacter pylori in duodenal ulcer bleeding: preliminary results of a pilot study. J Gastroenterol 1995 30 : 319 21.
28. Jensen DM, Savides T, Sitzer M, et al. Prevention of ulcer hemorrhage by H. pylori eradication. Gastroenterology 2003 124 (Suppl.1 135.
29. Krizman I, Ribnikar M, Kozjek F, Primozic S. Comparative amoxicillin-azithromycin treatment of Helicobacter pylori positive patients with bleeding duodenal ulcer. Acta Pharmaceutica 1997 47 : 183 8.
30. Labenz J, Borsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994 55 : 19 23.
31. Lai KC, Hui WM, Wong WM, et al. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage - a long-term randomized, controlled study. Am J Gastroenterol 2000 95 : 2225 32.
32. Lai KC, Hui WM, Lam SK, et al. Maintenance H2-antagonist is not necessary after eradication of Helicobacter pylori in bleeding peptic ulcers. Gastroenterology 1998 114 : A192.
33. Lee C, Wu CH, Chen TK, Tu TC, Chan CC, Lee SC. Maintenance anti-ulcer treatment is not necessary in patients with bleeding peptic ulcer after H. pylori eradication and ulcer healing. Gut 1999 45 (Suppl.3 A116.
34. Liu CC, Lee CL, Chan CC, et al. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study. Arch Intern Med 2003 163 : 2020 4.
35. Loperfido S, Priora R, Monica F, Salvat HH. Effect of Helicobacter pylori eradication on recurrence of bleeding duodenal ulcer and dyspeptic symptoms: a two-year prospective study. Gastroenterology 2001 120 (Suppl.1 A585.
36. Macri G, Milani S, Surrenti E, Passaleva MT, Salvadori G, Surrenti C. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-term follow-up study. Am J Gastroenterol 1998 93 : 925 7.
37. Pamos S, Lujan M, Canelles P, Orti E, Quiles F, Tome A. Erradicación del Helicobacter pylori y recidiva hemorrágica por ulcus gástrico. Rev Esp Enferm Dig 1998 90 (Suppl.I 136.
38. Pazzi P, Scagliarini R, Gamberini S, Rizzo C, Gullini S. Helicobacter pylori (Hp) eradication and reduction of duodenal ulcer (DU) bleeding relapse: a 4-year follow-up study. Gastroenterology 1999 116 : A278.
39. Pellicano R, Peyre S, Leone N, et al. The effect of the eradication of Helicobacter pylori infection on hemorrhage because of duodenal ulcer. J Clin Gastroenterol 2001 32 : 222 4.
40. Pica R, Marigani M, D'Ambra G, et al. One year H. pylori eradication in duodenal ulcer (DU) hypersecretory patients does not alter acid secretion but prevents ulcer relapse and bleeding. Gastroenterology 1996 111 : A250.
41. Riemann JF, Schilling D, Schauwecker P, et al. Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding. Gastrointest Endosc 1997 46 : 299 304.
42. Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995 41 : 1 4.
43. Santander C, Gravalos RG, Gomez-Cedenilla A, Cantero J, Pajares JM. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. Am J Gastroenterol 1996 91 : 1549 52.
44. Sung JJ, Leung WK, Suen R, et al. One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding. Dig Dis Sci 1997 42 : 2524 8.
45. Vcev A, Horvat D, Rubinic M, et al. Eradication of Helicobacter pylori reduces the possibility of rebleeding in duodenal ulcer disease. Acta Fam Med Flum 1996 21 : 59 65.
46. Vergara M, Casellas F, Saperas E, et al. Helicobacter pylori eradication prevents recurrence from peptic ulcer haemorrhage. Eur J Gastroenterol Hepatol 2000 12 : 733 7.
47. Sharma VK, Sahai AV, Corder FA, Howden CW. Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. Aliment Pharmacol Ther 2001 15 : 1939 47.
48. Gisbert JP, Pajares JM. Helicobacter pylori 'rescue' therapy after failure of two eradication treatments. Helicobacter 2005 10 : 363 72.
49. Gisbert JP. The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol 2005 100 : 2083 99.
50. Barthel JS. Bleeding ulcers and Helicobacter pylori. Gastrointest Endosc 1997 46 : 371 3.
51. Vergara M, Catalan M, Gisbert JP, Calvet X. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther 2005 21 : 1411 8.
52. Chan FK, Chung SC, Suen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001 344 : 967 73.
53. Lai KC, Lam SK, Chu KM, et al. Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users - a randomized trial. Aliment Pharmacol Ther 2003 18 : 829 36.
54. Lai KC, Lam SK, Chu KM, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002 346 : 2033 8.
55. Lachman L, Howden CW. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration. Am J Gastroenterol 2000 95 : 57 61.
56. Jonsson B. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease. Scand J Gastroenterol Suppl 1996 215 : 90 5.
57. Sonnenberg A, Pauly MP, Levenson SD, Schwartz JS. Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer. Am J Manag Care 1999 5 : 53 9.
58. Hood HM, Wark C, Burgess PA, Nicewander D, Scott MW. Screening for Helicobacter pylori and nonsteroidal anti-inflammatory drug use in medicare patients hospitalized with peptic ulcer disease. Arch Intern Med 1999 159 : 149 54.
59. Garrigan K, McIntosh C, Fraser AG. Bleeding peptic ulcers: audit of eradication treatment for H. pylori. N Z Med J 1999 112 : 178 80.
60. van Leerdam ME, Tytgat GN. Review article: Helicobacter pylori infection in peptic ulcer haemorrhage. Aliment Pharmacol Ther 2002 16 (Suppl.1 66 78.